Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+67.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+67.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$171.59M+20.3%
2024$142.60M+128.5%
2023$62.41M+71.4%
2022$36.41M+13.8%
2021$32.00M-